Provided by Tiger Trade Technology Pte. Ltd.

Allogene Therapeutics Inc.

1.73
0.0000
Volume:2.09M
Turnover:3.62M
Market Cap:596.85M
PE:-2.66
High:1.76
Open:1.73
Low:1.70
Close:1.73
52wk High:4.46
52wk Low:1.04
Shares:345.00M
Float Shares:262.00M
Volume Ratio:1.03
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6510
EPS(LYR):-0.8652
ROE:-42.39%
ROA:-22.08%
PB:1.37
PE(LYR):-2.00

Loading ...

Earnings Flash (ALLO) Allogene Therapeutics Posts Q1 Loss $0.18, vs. FactSet Est of $0.19 Loss

MT Newswires Live
·
May 14

Allogene Q1 net loss $42.6 million, or $0.18 a share; cash $266.9 million

Reuters
·
May 14

BRIEF-Allogene Therapeutics Q1 EPS USD -0.18

Reuters
·
May 14

Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update

THOMSON REUTERS
·
May 14

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 13

Allogene Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
May 12

Allogene Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
May 08

Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update

THOMSON REUTERS
·
May 06

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 06

Allogene wins South Korea, Australia regulatory clearance to expand ALPHA3 trial

Reuters
·
Apr 21

Allogene Therapeutics Expands Pivotal Phase 2 Alpha3 Trial to South Korea and Australia

THOMSON REUTERS
·
Apr 21

Allogene Therapeutics Inc - Interim Efs Analysis Anticipated in Mid-2027, Primary Efs Analysis in Mid-2028

THOMSON REUTERS
·
Apr 21

Allogene Therapeutics Inc - Patient Screening and Enrollment Expected to Begin in Q2 2026

THOMSON REUTERS
·
Apr 21

Allogene Therapeutics announces annual shareholder meeting notice

Reuters
·
Apr 21

Allogene Therapeutics to present allogeneic CAR-T data at AACR annual meeting

Reuters
·
Apr 20

Allogene presents preclinical BCMA/CD70 dual CAR-T data for multiple myeloma at AACR

Reuters
·
Apr 20

Press Release: Allogene Therapeutics Announces Closing of $200.4 Million Public Offering of Common Stock

Dow Jones
·
Apr 17

Allogene Therapeutics Inc : JP Morgan Raises to Neutral From Underweight

THOMSON REUTERS
·
Apr 16

U.S. RESEARCH ROUNDUP-CME Group, M&T Bank, PNC Financial Services

Reuters
·
Apr 16

NASD Most Active Issues

Dow Jones
·
Apr 16